Common Equity: The sum of all common equity items.
ImmunityBio, Inc. (IBRX) had Common Equity of $-585.94M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$0.62M |
|
$-583.20M |
|
-- |
|
$0.62M |
|
$362.87M |
|
$-362.25M |
|
$-221.64M |
|
$-583.89M |
|
$-583.89M |
|
$-583.85M |
|
$-583.85M |
|
$-583.85M |
|
$-583.85M |
|
$-362.25M |
|
$-301.48M |
|
508.64M |
|
508.64M |
|
$-1.15 |
|
$-1.15 |
|
| Balance Sheet Financials | |
$294.08M |
|
$146.08M |
|
$210.37M |
|
$504.45M |
|
$58.28M |
|
$681.54M |
|
$1.03B |
|
$1.09B |
|
|
Common Equity |
$-585.94M |
$-603.03M |
|
$-585.94M |
|
670.87M |
|
| Cash Flow Statement Financials | |
$-366.76M |
|
$-30.47M |
|
$558.34M |
|
$104.97M |
|
$265.79M |
|
$160.82M |
|
$49.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.05 |
|
-- |
|
-- |
|
7.13 |
|
-1.16 |
|
100.00% |
|
-58239.55% |
|
-58239.55% |
|
-48469.30% |
|
-93873.32% |
|
-93761.41% |
|
$-397.34M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
99.64% |
|
96.82% |
|
-115.74% |
|
-610.72% |
|
$-0.87 |
|
$-0.78 |
|
$-0.72 |
|